Question 3 - HIV Preexposure Prophylaxis (PrEP) Question Bank

HIV Preexposure Prophylaxis (PrEP)Question 3/10

A 33-year-old woman is seen in clinic to start injectable, long-acting cabotegravir-IM for HIV preexposure prophylaxis (PrEP).

The recommended dosing is 600 mg (3 mL) intramuscularly once, then repeated in 1 month, and then repeated every 2 months

A lead-in period of 28 days taking oral cabotegravir is required before receiving the first intramuscular dose

The intramuscular dose should be increased from 600 mg (3 mL) to 800 mg (4 mL) if a person’s body mass index (BMI) is greater than 50

The medication can be administered in a clinic or by the patient at home after training by a health care professional

Illustration: David H. Spach, MD

Prev Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.

Question Last Updated
August 5th, 2026